First Time Loading...

China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294

Watchlist Manager
China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd
SZSE:300294
Watchlist
Price: 27.78 CNY -0.89% Market Closed
Updated: Mar 29, 2024

Intrinsic Value

Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. [ Read More ]

The intrinsic value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is 27.45 CNY. Compared to the current market price of 27.78 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is Overvalued by 1%.

Key Points:
Intrinsic Value
Base Case
27.45 CNY
Overvaluation 1%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
China Resources Boya Bio pharmaceutical Group Co Ltd

Backtest China Resources Boya Bio pharmaceutical Group Co Ltd Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling China Resources Boya Bio pharmaceutical Group Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

How can I assist you today?

Provide an overview
of China Resources Boya Bio pharmaceutical Group Co Ltd's business.

What risks and challenges
does China Resources Boya Bio pharmaceutical Group Co Ltd face in the near future?

Summarize the latest earnings report
of China Resources Boya Bio pharmaceutical Group Co Ltd.

Provide P/E
for China Resources Boya Bio pharmaceutical Group Co Ltd and its competitors.

Financials

Balance Sheet Decomposition
China Resources Boya Bio pharmaceutical Group Co Ltd

Current Assets 6.4B
Cash & Short-Term Investments 5.1B
Receivables 685.9m
Other Current Assets 583.8m
Non-Current Assets 1.8B
Long-Term Investments 112.5m
PP&E 711.8m
Intangibles 866m
Other Non-Current Assets 113.3m
Current Liabilities 556.3m
Accounts Payable 102.9m
Accrued Liabilities 89.6m
Short-Term Debt 38m
Other Current Liabilities 325.7m
Non-Current Liabilities 75m
Long-Term Debt 23.8m
Other Non-Current Liabilities 51.2m
Efficiency

Earnings Waterfall
China Resources Boya Bio pharmaceutical Group Co Ltd

Revenue
2.9B CNY
Cost of Revenue
-1.4B CNY
Gross Profit
1.4B CNY
Operating Expenses
-954m CNY
Operating Income
482.2m CNY
Other Expenses
-4.2m CNY
Net Income
478m CNY

Free Cash Flow Analysis
China Resources Boya Bio pharmaceutical Group Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

China Resources Boya Bio pharmaceutical Group Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

57/100
Profitability
Score

China Resources Boya Bio pharmaceutical Group Co Ltd's profitability score is 57/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

China Resources Boya Bio pharmaceutical Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
87/100
Solvency
Score

China Resources Boya Bio pharmaceutical Group Co Ltd's solvency score is 87/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
China Resources Boya Bio pharmaceutical Group Co Ltd

Wall Street analysts forecast China Resources Boya Bio pharmaceutical Group Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for China Resources Boya Bio pharmaceutical Group Co Ltd is 35.96 CNY with a low forecast of 31.08 CNY and a high forecast of 40.95 CNY.

Lowest
Price Target
31.08 CNY
12% Upside
Average
Price Target
35.96 CNY
29% Upside
Highest
Price Target
40.95 CNY
47% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
China Resources Boya Bio pharmaceutical Group Co Ltd

1M 1M
-3%
6M 6M
-10%
1Y 1Y
-16%
3Y 3Y
+3%
5Y 5Y
-6%
10Y 10Y
+207%
Annual Price Range
27.78
52w Low
23.7
52w High
38.66
Price Metrics
Average Annual Return 6.51%
Standard Deviation of Annual Returns 4.74%
Max Drawdown -59%
Shares Statistics
Market Capitalization 14B CNY
Shares Outstanding 504 248 738
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

China Resources Boya Bio pharmaceutical Group Co Ltd Logo
China Resources Boya Bio pharmaceutical Group Co Ltd

Country

China

Industry

Biotechnology

Market Cap

14B CNY

Dividend Yield

0.71%

Description

Boya Bio-pharmaceutical Group Co., Ltd. engages in the research, development, production, and sale of blood products. The company is headquartered in Fuzhou, Jiangxi and currently employs 1,652 full-time employees. The company went IPO on 2012-03-08. The firm's main products include human albumin, freeze-drying intravenous injection human immune globulin, human immune globulin, hepatitis B human immune globulin, hydrophobia human immune globulin, human fibrinogen, metformin hydrochloride, calcium dobesilate capsules, glimepiride and pioglitazone hydrochloride dispersible tablets, among others. The firm's blood products are mainly used in the treatment of tumor, liver diseases and diabetes, among others. The firm also provides diabetic pharmaceuticals and biochemical pharmaceuticals. The firm distributes its products mainly in domestic market.

Contact

JIANGXI
Fuzhou
No. 333, Huiquan Road, High-tech Industrial Development Zone
+867948264398
http://www.china-boya.com

IPO

2012-03-08

Employees

1 652

Officers

GM & Non-Independent Director
Mr. Xinxi Liao

See Also

Discover More
What is the Intrinsic Value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock?

The intrinsic value of one China Resources Boya Bio pharmaceutical Group Co Ltd stock under the Base Case scenario is 27.45 CNY.

Is China Resources Boya Bio pharmaceutical Group Co Ltd stock undervalued or overvalued?

Compared to the current market price of 27.78 CNY, China Resources Boya Bio pharmaceutical Group Co Ltd is Overvalued by 1%.